Exhibit 10.1
NGM BIOPHARMACEUTICALS, INC.
2008 EQUITY INCENTIVE PLAN
ADOPTEDBYTHE BOARDOF DIRECTORS: JANUARY 18, 2008
APPROVEDBYTHE STOCKHOLDERS: JANUARY 18, 2008
AMENDEDBYTHE BOARDOF DIRECTORS: MARCH 9, 2010
AMENDEDBY STOCKHOLDERS: MARCH 9, 2010
AMENDEDBYTHE BOARDOF DIRECTORS: FEBRUARY 11, 2011
AMENDEDBY STOCKHOLDERS: FEBRUARY 22, 2011
AMENDEDBYTHE BOARDOF DIRECTORS: DECEMBER 4, 2012
AMENDEDBYTHE BOARDOF DIRECTORS: MARCH 28, 2013
AMENDEDBY STOCKHOLDERS: MARCH 29, 2013
AMENDEDBYTHE BOARDOF DIRECTORS: DECEMBER 12, 2014
AMENDEDBY STOCKHOLDERS: FEBRUARY 18, 2015
AMENDEDBYTHE BOARDOF DIRECTORS: DECEMBER 8, 2015
AMENDEDBY STOCKHOLDERS: MARCH 14, 2016
AMENDEDBYTHE BOARDOF DIRECTORS: DECEMBER 6, 2016
AMENDEDBY STOCKHOLDERS: NOVEMBER 27, 2017
TERMINATION DATE: JANUARY 17, 2018
(a)Eligible Stock Award Recipients. The persons eligible to receive Stock Awards are Employees, Directors and Consultants.
(b)Available Stock Awards. The Plan provides for the grant of the following Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Restricted Stock Awards, (iv) Restricted Stock Unit Awards, and (v) Stock Appreciation Rights.
(c)Purpose. The Company, by means of the Plan, seeks to secure and retain the services of the group of persons eligible to receive Stock Awards as set forth in Section 1(a), to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate, and to provide a means by which such eligible recipients may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Stock Awards.
(a)Administration by Board. The Board shall administer the Plan unless and until the Board delegates administration of the Plan to a Committee, as provided in Section 2(c).
1